Evotec
Investor profile
Venture capital
Evotec has backed 2 European tech companies across 2 funding rounds between 2021 and 2022, joining rounds totalling €78M. Most active in Healthtech. Data as of Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2021–2022
2 yrs
Total round €
€78M
sum of rounds joined
Deals by year
distinct rounds / yearEvotec — deals by year — interactive chart.
Data table
| Evotec — deals by year | |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
Top sectors
by dealsEvotec — top sectors — interactive chart.
Data table
| Evotec — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsEvotec — stages — interactive chart.
Data table
| Evotec — stages | |
|---|---|
| Series B | 2 |
Countries
by dealsEvotec — countries — interactive chart.
Data table
| Evotec — countries | |
|---|---|
| Germany | 2 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tubulis Technologies | Germany | 1 | €60M |
| Topas Therapeutics | Germany | 1 | €18M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Tubulis Technologies | Series B | €60M | 2022-05 |
| Topas Therapeutics | Series B | €18M | 2021-07 |